BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1204 related articles for article (PubMed ID: 12207335)

  • 1. Recognition of core and flanking amino acids of MHC class II-bound peptides by the T cell receptor.
    Sant'Angelo DB; Robinson E; Janeway CA; Denzin LK
    Eur J Immunol; 2002 Sep; 32(9):2510-20. PubMed ID: 12207335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates.
    Morkowski S; Goldrath AW; Eastman S; Ramachandra L; Freed DC; Whiteley P; Rudensky AYu
    J Exp Med; 1995 Nov; 182(5):1403-13. PubMed ID: 7595211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling alternative binding registers of a minimal immunogenic peptide on two class II major histocompatibility complex (MHC II) molecules predicts polarized T-cell receptor (TCR) contact positions.
    Murray JS; Fois SD; Schountz T; Ford SR; Tawde MD; Brown JC; Siahaan TJ
    J Pept Res; 2002 Mar; 59(3):115-22. PubMed ID: 11985705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage.
    Carson RT; Vignali KM; Woodland DL; Vignali DA
    Immunity; 1997 Sep; 7(3):387-99. PubMed ID: 9324359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An endogenously processed self peptide and the corresponding exogenous peptide bound to the same MHC class II molecule could be distinct ligands for TCR with different kinetic stability.
    Gyotoku T; Fukui Y; Sasazuki T
    Eur J Immunol; 1998 Dec; 28(12):4050-61. PubMed ID: 9862341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A molecular basis for how a single TCR interfaces multiple ligands.
    Boesteanu A; Brehm M; Mylin LM; Christianson GJ; Tevethia SS; Roopenian DC; Joyce S
    J Immunol; 1998 Nov; 161(9):4719-27. PubMed ID: 9794402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II MHC molecule.
    Takeshita T; Takahashi H; Kozlowski S; Ahlers JD; Pendleton CD; Moore RL; Nakagawa Y; Yokomuro K; Fox BS; Margulies DH
    J Immunol; 1995 Feb; 154(4):1973-86. PubMed ID: 7530749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition.
    Boehncke WH; Takeshita T; Pendleton CD; Houghten RA; Sadegh-Nasseri S; Racioppi L; Berzofsky JA; Germain RN
    J Immunol; 1993 Jan; 150(2):331-41. PubMed ID: 8093457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The crystal structure of a T cell receptor in complex with peptide and MHC class II.
    Reinherz EL; Tan K; Tang L; Kern P; Liu J; Xiong Y; Hussey RE; Smolyar A; Hare B; Zhang R; Joachimiak A; Chang HC; Wagner G; Wang J
    Science; 1999 Dec; 286(5446):1913-21. PubMed ID: 10583947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence variability analysis of human class I and class II MHC molecules: functional and structural correlates of amino acid polymorphisms.
    Reche PA; Reinherz EL
    J Mol Biol; 2003 Aug; 331(3):623-41. PubMed ID: 12899833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino acid residues that flank core peptide epitopes and the extracellular domains of CD4 modulate differential signaling through the T cell receptor.
    Vignali DA; Strominger JL
    J Exp Med; 1994 Jun; 179(6):1945-56. PubMed ID: 7515103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of TCR recognition of MHC class II/peptide by processed remote N- and C-terminal epitope extensions.
    Bonomi G; Moschella F; Ombra MN; Del Pozzo G; Granier C; De Berardinis P; Guardiola J
    Hum Immunol; 2000 Aug; 61(8):753-63. PubMed ID: 10980386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional mapping of MHC class II polymorphic residues. The alpha-chain controls the specificity for binding an Ad-versus an A k-restricted peptide and the beta-chain region 65-67 controls T cell recognition but not peptide binding.
    Lee JM; McKean DJ; Watts TH
    J Immunol; 1991 May; 146(9):2952-9. PubMed ID: 1849939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The majority of immunogenic epitopes generate CD4+ T cells that are dependent on MHC class II-bound peptide-flanking residues.
    Arnold PY; La Gruta NL; Miller T; Vignali KM; Adams PS; Woodland DL; Vignali DA
    J Immunol; 2002 Jul; 169(2):739-49. PubMed ID: 12097376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited plasticity in T cell recognition of modified T cell receptor contact residues in MHC class II bound peptides.
    de Haan EC; Wagenaar-Hilbers JP; Liskamp RM; Moret EE; Wauben MH
    Mol Immunol; 2005 Feb; 42(3):355-64. PubMed ID: 15589324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The alloreactive and self-restricted CD4+ T cell response directed against a single MHC class II/peptide combination.
    Kovalik JP; Singh N; Mendiratta SK; Martin WD; Ignatowicz L; Van Kaer L
    J Immunol; 2000 Aug; 165(3):1285-93. PubMed ID: 10903728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of a specific self-peptide: self-MHC class II complex is critical for positive selection of thymocytes expressing the D10 TCR.
    Dao T; Blander JM; Sant'Angelo DB
    J Immunol; 2003 Jan; 170(1):48-54. PubMed ID: 12496382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structures of an MHC class II molecule with covalently bound single peptides.
    Fremont DH; Hendrickson WA; Marrack P; Kappler J
    Science; 1996 May; 272(5264):1001-4. PubMed ID: 8638119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method.
    Nielsen M; Lundegaard C; Lund O
    BMC Bioinformatics; 2007 Jul; 8():238. PubMed ID: 17608956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloned T cells internalize peptide from bound complexes of peptide and purified class II major histocompatibility complex antigen.
    Nag B; Deshpande SV; Sharma SD; Clark BR
    J Biol Chem; 1993 Jul; 268(19):14360-6. PubMed ID: 7686154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.